Transcatheter device closure of atrial septal defects

O’Byrne, Michael L.; Glatz, Andrew C.; Gillespie, Matthew J.

doi:10.1097/hco.0000000000000476

Cited by 9 publications

(2 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Transthoracic and transcatheter device closures of ASDs have been increasingly reported in recent years; the previous reports also confirmed that there were low morbidity and mortality in both treatments [ 5 , 6 ] . With the accumulation of experience and the progression of technology, these two treatments have tended to replace surgical repair for the treatment of ASDs [ 10 ] . Transcatheter device closure of ASDs has the advantages of no incision and a short hospitalization time [ 11 , 12 ] .…”

Section: Discussionmentioning

confidence: 99%

Comparison of Postoperative Changes in Inflammatory Marker Levels Between Transthoracic and Transcatheter Device Closures of Atrial Septal Defects in Children

Hong

Huang

Kim

et al. 2020

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

Objective To explore the postoperative changes in inflammatory markers in children who underwent device closure of an atrial septal defect (ASD) via a transthoracic or transcatheter approach. Methods The experimental and clinical data were retrospectively collected and analyzed for a total of 53 pediatric patients between September 2018 and December 2018. According to the different treatments, 19 patients who underwent transthoracic device closure were assigned to group A, and the remaining 34 patients who underwent a transcatheter approach were assigned to group B. Results All patients were successfully occluded without any device-related severe complication. Compared with the preoperative levels, the postoperative levels of most inflammatory cytokines in both groups were significantly increased and reached a peak on the first day after the procedure. The level of postoperative inflammatory cytokines was significantly lower in group B than in group A. In addition, there was no significant difference in procalcitonin before and after the transcatheter approach. Conclusion Systemic inflammatory reactions occurred after transthoracic or transcatheter device closure of ASDs in pediatric patients. However, these inflammatory reactions were more significant in patients who underwent a transthoracic approach than in patients who underwent a transcatheter approach.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of Postoperative Changes in Inflammatory Marker Levels Between Transthoracic and Transcatheter Device Closures of Atrial Septal Defects in Children

Hong

Huang

Kim

et al. 2020

Braz J Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

“…Since proven effective, transthoracic echocardiography (TTE)-guided percutaneous ASD closure (the PAN procedure) has been performed in an increasing numbers of patients [ 2 – 4 ] avoiding exposure to radiation and use of lead suit protection [ 5 ]. However, mastering the PAN procedure requires getting used to guidance by echocardiographic plane-by-plane scanning instead of fluoroscopic 3D image projections onto a 2D plane which facilitates finding the guide wire tip [ 4 , 6 ]. To overcome the latter learning curve limitation and the fact that available guide wires were designed for fluoroscopic and not for echocardiographic guidance, we designed a novel guide wire with a spindle tip, specialized for ultrasound guidance.…”

Section: Introductionmentioning

confidence: 99%

A Novel Wire Is Effective for Echo-Guiding Percutaneous Atrial Septal Defect Closure: A Preclinical Study

Liu

Guo

Zhang

et al. 2018

Journal of Healthcare Engineering

View full text Add to dashboard Cite

Objective To assess the effectiveness of a novel ultrasound wire for echo-guiding percutaneous atrial septal defect (ASD) closure in a sheep model. Methods After right lateral thoracotomy, ASDs were created in 20 sheep by transseptal needle puncture followed by balloon dilatation. Animals were evenly randomized into 2 groups to undergo ASD closure using echography as the only imaging tool with either COOK wire (control group) or new ultrasound wire (study group). The total procedural time, passing time (time needed for the guide wire to enter the left atrium), frequency of delivery sheath dropping into the right atrium, frequency of arrhythmias, and 1-week rate of complications were compared between the two groups. Results All animals survived defect creation procedures uneventfully. ASD devices were successfully implanted in all sheep. Compared with the control group, the study group had significantly (P < 0.05) lower mean procedure time (15.36 ± 4.86 versus 25.82 ± 7.85 min), lower mean passing time (2.69 ± 0.82 versus 5.58 ± 3.34 min), lower frequency of the guide wire dropping into the right atrium (0% versus 40%), and lower frequency of atrial (4.41 ± 2.61 versus 9.60 ± 3.68) or ventricular premature contractions (0.75 ± 0.36 versus 1.34 ± 0.68), respectively, without serious complications up to one week. Conclusion The novel ultrasound specialized guide wire was effective in echo-guiding percutaneous ASD closure.

show abstract

A 29‐Year‐Old Woman with Shortness of Breath and Leg Swelling

2019

Cardiology Board Review

View full text Add to dashboard Cite

Transcatheter device closure of atrial septal defects

Abstract: As TC-ASD and congenital interventional cardiology mature as a field, studies of real-world practice provide increasingly valuable information about aspects of care in which there are disagreements about best practices and in which further research is necessary.

Cited by 9 publications

References 81 publications

Comparison of Postoperative Changes in Inflammatory Marker Levels Between Transthoracic and Transcatheter Device Closures of Atrial Septal Defects in Children

Comparison of Postoperative Changes in Inflammatory Marker Levels Between Transthoracic and Transcatheter Device Closures of Atrial Septal Defects in Children

A Novel Wire Is Effective for Echo-Guiding Percutaneous Atrial Septal Defect Closure: A Preclinical Study

A 29‐Year‐Old Woman with Shortness of Breath and Leg Swelling

Contact Info

Product

Resources

About